THAILAND: Aids lobby slams pharma patent ploy

Aids advocacy groups have opposed a move by a company that owns the patent to a life-saving drug that will prevent its competitors from making and selling the drug in Thailand. Merck Sharp & Dohme (MSD) holds the patent for Raltegravir, an expensive antiretroviral drug, which the groups say is the only option for many HIV/Aids patients as they have developed resistance to other drugs. “There is the only one trademarked Raltegravir sold in Thailand and it costs 13,620 baht per month,” said Apiwat Kwangkaew, president of the Thai Network of People Living with HIV/Aids.

read more

Advertisements
This entry was posted in Thai general news and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s